PDCD1 and neoplasm: Concurrently, ICD induces IFN-γ secretion, upregulating PD-L1 on tumor cells and myeloid cells—a feedback mechanism that ICIs (anti-PD-1/PD-L1) exploit to sustain T-cell function [147, 148].